Purchase Order FA520917P0038
Award Date 1/25/17
Potential Completion Date 11/26/17
Potential Value $125K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Department of the Army Materiel Command Research Development and Engineering Command awarded a firm fixed price purchase order to Nippon Medical & Chemical Instruments Co., LTD., a for-profit organization, for the improvement of cell-based therapy for bone injury. The $125,000.00 contract was awarded on September 18, 2017, with a completion date of October 17, 2018. The contract was not set aside for any specific business type. The place of performance is Japan.</p>
- <p>This federal contract was awarded by the Department of the Army Medical Command to Epibone, Inc., a for-profit organization, for an SBIR (Small Business Innovation Research) Program Phase I project titled "Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler." The contract has a firm fixed-price of $148,990.22 and a completion date of March 14, 2018. The contract is set aside for small businesses and the place of performance is Brooklyn, NY 11226, USA.</p>
- This federal contract award, valued at $7,307,350.45, was granted to the Medical Technology Enterprise Consortium (MTEC), a non-profit organization that serves as a medical technology accelerator for the U.S. Department of Defense. The award is for the development of prototype solutions for peripheral nerve injury, including a novel cell-based therapy to treat muscle atrophy and an injectable gel for restoration of neuromuscular function and accelerated innervation of 3D bioprinted muscle...
- <p>The Department of the Army Medical Command awarded a Small Business Innovation Research (SBIR) Phase I contract to Epibone, Inc., a for-profit organization. The contract, valued at $149,126.38, was awarded on May 15, 2017 and is scheduled for completion on April 14, 2018. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the place of performance is Fort Detrick, MD 21702, USA.</p>
- This contract award is for the provision of advanced medical technologies, including bone morphogenetic protein fiber, to the U.S. federal government. The prime contractor is Red One Medical Devices LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that specializes in delivering innovative prosthetics, orthotics, surgical implants, and other cutting-edge medical devices to support the healthcare needs of America's veterans and wounded warriors. The contract has a ceiling value of...
- This is a $3,771,693.99 firm-fixed price contract awarded by the Defense Health Agency to The Geneva Foundation, a non-profit organization, to provide adaptive orthopedic biologics research and development services. The contract was not set aside. Major subcontractors include the South Australian Health and Medical Research Institute, Akron Biotechnology, and the Cleveland Clinic Foundation, who are providing specialized expertise, production methods, and testing for the development of a...
- This is a $74,481 firm-fixed-price purchase order contract awarded by the Air Force Research Laboratory (AFRL) to Epibone, Inc., a small business, to provide a "Solution to Provide Cartilage Replacement for Long-Term and Progressive Usage." The contract is part of the Small Business Innovation Research (SBIR) Program Phase I and is focused on developing innovative bone reconstruction solutions for military personnel suffering from severe bone trauma. Epibone, a for-profit...
- <p>This is a $98,800.00 firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Elutia Inc., a for-profit manufacturer, for the supply of VIBONE Cellular Allograft. The contract has an ultimate completion date of September 30, 2019 and does not have a set-aside designation. This award appears to be for a standalone procurement and is not associated with a larger contract vehicle.</p>
- The federal contract award summarized in the information provided is a purchase order issued by the Defense Health Agency (DHA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The $40,910.00 firm fixed price contract is for the delivery of Cellular Bone Matrix Medium 5CC, a specialized spinal implant. This contract award is part of a $8 million single-award Blanket Purchase Agreement (BPA) between Nuvasive and DHA, which serves as a streamlined...
- This is a Blanket Purchase Agreement (BPA) call award to Lifenet Health, a non-profit organization and manufacturer of regenerative medicine products, by the U.S. Army Medical Command. The contract, valued at $5,000,000.00, is for the month of November 2016 and does not have a set-aside designation. Under this BPA, Lifenet Health will provide a variety of human tissue and cellular products, such as postmortem brain tissue, cellular bone matrix grafts, saphenous veins, and osteochondral dowels,...